Loading...
Randomized Phase II Trial Designs With Biomarkers
Efficient development of targeted therapies that may only benefit a fraction of patients requires clinical trial designs that use biomarkers to identify sensitive subpopulations. Various randomized phase III trial designs have been proposed for definitive evaluation of new targeted treatments and th...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3434989/ https://ncbi.nlm.nih.gov/pubmed/22869885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.3946 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|